|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mertens-Walker I, Baxter RC and Marsh DJ:
Gonadotropin signalling in epithelial ovarian cancer. Cancer Lett.
324:152–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong Z, Yang L and Lai D: KLF5 strengthens
drug resistance of ovarian cancer stem-like cells by regulating
survivin expression. Cell Prolif. 46:425–435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duiker EW, Meijer A, van der Bilt AR,
Meersma GJ, Kooi N, van der Zee AGJ, de Vries EG and de Jong S:
Drug-induced caspase 8 upregulation sensitises cisplatin-resistant
ovarian carcinoma cells to rhTRAIL-induced apoptosis. Br J Cancer.
104:1278–1287. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang Y, Jin H, Liu Y, Zhou J, Ding J,
Cheng KW, Yu Y and Feng Y: FSH inhibits ovarian cancer cell
apoptosis by up-regulating survivin and down-regulating PDCD6 and
DR5. Endocr Relat Cancer. 18:13–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vito P, Lacanà E and D'Adamio L:
Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and
Alzheimer's disease gene ALG-3. Science. 271:521–525. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su D, Xu H, Feng J, Gao Y, Gu L, Ying L,
Katsaros D, Yu H, Xu S and Qi M: PDCD6 is an independent predictor
of progression free survival in epithelial ovarian cancer. J Transl
Med. 10:312012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brodowska A, Laszczyńska M, Brodowski J,
Masiuk M and Starczewski A: Analysis of pituitary gonadotropin
concentration in blood serum and immunolocalization and
immunoexpression of follicle stimulating hormone and luteinising
hormone receptors in ovaries of postmenopausal women. Histol
Histopathol. 27:241–248. 2012.PubMed/NCBI
|
|
9
|
Ohtani K, Sakamoto H and Satoh K:
Stimulatory effects of follicular stimulating hormone on the
proliferation of ovarian cancer cell line in vitro and in
vivo. Nihon Sanka Fujinka Gakkai Zasshi. 44:717–724. 1992.(In
Japanese). PubMed/NCBI
|
|
10
|
Zheng W, Lu JJ, Luo F, Zheng Y, Feng Y,
Felix JC, Lauchlan SC and Pike MC: Ovarian epithelial tumor growth
promotion by follicle-stimulating hormone and inhibition of the
effect by luteinizing hormone. Gynecol Oncol. 76:80–88. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choi JH, Choi KC, Auersperg N and Leung
PC: Gonadotropins upregulate the epidermal growth factor receptor
through activation of mitogen-activated protein kinases and
phosphatidyl-inositol-3-kinase in human ovarian surface epithelial
cells. Endocr Relat Cancer. 12:407–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi JH, Choi KC, Auersperg N and Leung
PC: Gonadotropins activate proteolysis and increase invasion
through protein kinase A and phosphatidylinositol 3-kinase pathways
in human epithelial ovarian cancer cells. Cancer Res. 66:3912–3920.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao JX, Liu H, Lv J and Yang XJ:
Wortmannin enhances cisplatin-induced apoptosis in human ovarian
cancer cells in vitro. Eur Rev Med Pharmacol Sci.
18:2428–2434. 2014.PubMed/NCBI
|
|
14
|
Kuroda H, Mandai M, Konishi I, Yura Y,
Tsuruta Y, Hamid AA, Nanbu K, Matsushita K and Mori T: Human
chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis
in ovarian cancer cells: possible role of up-regulation of
insulin-like growth factor-1 by hCG. Int J Cancer. 76:571–578.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Z, Liao H, Chen X, Zheng Y, Liu Y,
Tao X, Gu C, Dong L, Duan T, Yang Y, et al: Luteinizing hormone
upregulates survivin and inhibits apoptosis in ovarian epithelial
tumors. Eur J Obstet Gynecol Reprod Biol. 155:69–74. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoon JH, Choi YJ, Kim SG, Nam SW, Lee JY
and Park WS: Programmed cell death 6 (PDCD6) as a prognostic marker
for gastric cancers. Tumour Biol. 33:485–494. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park SH, Lee JH, Lee GB, Byun HJ, Kim BR,
Park CY, Kim HB and Rho SB: PDCD6 additively cooperates with
anti-cancer drugs through activation of NF-κB pathways. Cell
Signal. 24:726–733. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pon YL, Auersperg N and Wong AS:
Gonadotropins regulate N-cadherin-mediated human ovarian surface
epithelial cell survival at both post-translational and
transcriptional levels through a cyclic AMP/protein kinase A
pathway. J Biol Chem. 280:15438–15448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi JH, Chen CL, Poon SL, Wang HS and
Leung PC: Gonadotropin-stimulated epidermal growth factor receptor
expression in human ovarian surface epithelial cells: Involvement
of cyclic AMP-dependent exchange protein activated by cAMP pathway.
Endocr Relat Cancer. 16:179–188. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ohtani K, Sakamoto H, Kikuchi A, Nakayama
Y, Idei T, Igarashi N, Matukawa T and Satoh K: Follicle-stimulating
hormone promotes the growth of human epithelial ovarian cancer
cells through the protein kinase C-mediated system. Cancer Lett.
166:207–213. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang Y, Hua K, Zhou X, Jin H, Chen X, Lu
X, Yu Y, Zha X and Feng Y: Activation of the PI3K/AKT pathway
mediates FSH-stimulated VEGF expression in ovarian serous
cystadenocarcinoma. Cell Res. 18:780–791. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Slot KA, de Boer-Brouwer M, Houweling M,
Vaandrager AB, Dorrington JH and Teerds KJ: Luteinizing hormone
inhibits Fas-induced apoptosis in ovarian surface epithelial cell
lines. J Endocrinol. 188:227–239. 2006. View Article : Google Scholar : PubMed/NCBI
|
